A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
Lecanemab, marketed as Leqembi, is the first drug for Alzheimer’s disease to receive approval on the basis of clinically slowing the progression of Alzheimer’s disease.
A study of professionals in the National Hockey League found that players who frequently engaged in fighting on the ice died a decade earlier than less pugilistic players.
Age-related memory loss is caused, in part, by lack of flavanols—nutrients found in certain fruits and vegetables—according to a large study in older adults.
Attending a high school with a high number of teachers with graduate training was the clearest predictor of the impact of school quality on late-life cognition, researchers found.
With the help of a Columbia neurologist, a support group of Black Parkinson's patients has created a book for Black patients and their families written by the true experts: themselves.
Columbia Nursing researchers are using AI analysis of voice recordings to find a quick, inexpensive way to screen home care patients for early dementia.